1 / 5

Prodrugs

Prodrugs. Initial definition : A pharmacologically inactive chemical entity that when metabolized or chemically transformed by a mammalian system is converted into a pharmacologically active substance “ Drug Latentiation ” – included later

violet-yang
Download Presentation

Prodrugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Prodrugs • Initial definition: A pharmacologically inactive chemical entity that when metabolized or chemically transformed by a mammalian system is converted into a pharmacologically active substance • “Drug Latentiation” – included later • Process of purposely designing and synthesizing a molecule that specifically requires “bioactivation” to a pharmacologically active substance • Why use prodrugs? • Improve patient acceptability (decrease pain on injection) • Alter and improve absorption • Alter biodistribution • Alter metabolism • Alter elimination

  2. Non-Prodrugs • “Hard Drugs” - compounds that contain structural characteristics required for activity but are not susceptible to metabolism • Increased efficiency by avoiding metabolism • No toxic metabolites are formed • HOWEVER, less readily eliminated due to lack of metabolism • “Soft Drugs” - These are the opposite of prodrugs. These compounds are designed and synthesized as ACTIVEcompounds that readily undergo metabolic inactivation to nontoxic products

  3. Conversion of Prodrugs • Metabolism (enzyme dependant) • Chemical Methods (non-dependant) • Hydrolysis • Decarboxylation • NOT patient dependant! • Stability/Storage issues

  4. Prodrugs • Carrier-linked prodrugs – drugs that are attached through a metabolically labile chemical linkage to another molecule designated as the “promoiety” • The “promoiety” alters the physical properites of the drug to increase water or fat solubility or provide site-directed delivery • Advantages: • Increased absorption • Injection site pain relief • Elimination of unpleasant taste • Decreased toxicity • Decreased metabolic inactivation • Increased chemical stability • Prolonged or shortened action

  5. Chloramphenicol • Enzymatic and intramolecular spontaneous hydrolysis • Increased water solubility, ester itself is inactive as an antibiotic • Promoiety should be nontoxic and easily excreted • Type of promoiety chosen is a function of properties desired

More Related